Clinical outcome of biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with diabetes

BACKGROUND: Diabetes mellitus is a risk for increased incidence of adverse clinical events after percutaneous coronary intervention. However, the difference in the incidence of adverse clinical events according to stent type in patients with diabetes remains to be elucidated. In the present study, w...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cardiovasc Diabetol
Autors principals: Kakizaki, Ryota, Minami, Yoshiyasu, Katamine, Masahiro, Katsura, Aritomo, Muramatsu, Yusuke, Hashimoto, Takuya, Meguro, Kentaro, Shimohama, Takao, Ako, Junya
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7531093/
https://ncbi.nlm.nih.gov/pubmed/33004019
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-020-01145-x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars